Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Total 13F shares
-
10,263,556
-
Share change
-
+1,108,256
-
Total reported value
-
$101,043,565
-
Price per share
-
$9.85
-
Number of holders
-
46
-
Value change
-
+$10,817,004
-
Number of buys
-
29
-
Number of sells
-
10
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2016
As of 30 Jun 2016,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,263,556 shares.
The largest 10 holders included
MPM ASSET MANAGEMENT LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Advisors LLC, ORBIMED ADVISORS LLC, JENNISON ASSOCIATES LLC, EcoR1 Capital, LLC, Redmile Group, LLC, Boxer Capital, LLC, and Cormorant Asset Management, LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.